These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
115 related items for PubMed ID: 25072280
1. The synergistic effect of organic silicone quaternary ammonium salt and 5-fluorouracil on hepatocellular carcinoma in vitro and in vivo. Wang JX, Zhang LY, Zhang J, Ding H, Wang DM, Wang ZP. Eur J Cancer Prev; 2014 Sep; 23(5):372-84. PubMed ID: 25072280 [Abstract] [Full Text] [Related]
2. The monoclonal antibody CH12 augments 5-fluorouracil-induced growth suppression of hepatocellular carcinoma xenografts expressing epidermal growth factor receptor variant III. Jiang H, Dong Q, Luo X, Shi B, Wang H, Gao H, Kong J, Zhang J, Li Z. Cancer Lett; 2014 Jan 01; 342(1):113-20. PubMed ID: 24007863 [Abstract] [Full Text] [Related]
3. Opsin3 sensitizes hepatocellular carcinoma cells to 5-fluorouracil treatment by regulating the apoptotic pathway. Jiao J, Hong S, Zhang J, Ma L, Sun Y, Zhang D, Shen B, Zhu C. Cancer Lett; 2012 Jul 01; 320(1):96-103. PubMed ID: 22313545 [Abstract] [Full Text] [Related]
4. PTK787/ZK222584 combined with interferon alpha and 5-fluorouracil synergistically inhibits VEGF signaling pathway in hepatocellular carcinoma. Katsura Y, Wada H, Murakami M, Akita H, Hama N, Kawamoto K, Kobayashi S, Marubashi S, Eguchi H, Tanemura M, Umeshita K, Doki Y, Mori M, Nagano H. Ann Surg Oncol; 2013 Dec 01; 20 Suppl 3():S517-26. PubMed ID: 23508585 [Abstract] [Full Text] [Related]
5. 5-Fluorouracil combined with apigenin enhances anticancer activity through mitochondrial membrane potential (ΔΨm)-mediated apoptosis in hepatocellular carcinoma. Hu XY, Liang JY, Guo XJ, Liu L, Guo YB. Clin Exp Pharmacol Physiol; 2015 Feb 01; 42(2):146-53. PubMed ID: 25363523 [Abstract] [Full Text] [Related]
6. Water extract of Hedyotis Diffusa Willd suppresses proliferation of human HepG2 cells and potentiates the anticancer efficacy of low-dose 5-fluorouracil by inhibiting the CDK2-E2F1 pathway. Chen XZ, Cao ZY, Chen TS, Zhang YQ, Liu ZZ, Su YT, Liao LM, Du J. Oncol Rep; 2012 Aug 01; 28(2):742-8. PubMed ID: 22641337 [Abstract] [Full Text] [Related]
7. Suberoylanilide hydroxamic acid enhances chemosensitivity to 5-fluorouracil in hepatocellular carcinoma via inhibition of thymidylate synthase. Liao B, Liang H, Chen J, Liu Q, Zhang B, Chen X. Tumour Biol; 2015 Dec 01; 36(12):9347-56. PubMed ID: 26108995 [Abstract] [Full Text] [Related]
10. Oxymatrine synergistically enhances the inhibitory effect of 5-fluorouracil on hepatocellular carcinoma in vitro and in vivo. Liu Y, Bi T, Dai W, Wang G, Qian L, Gao Q, Shen G. Tumour Biol; 2016 Jun 01; 37(6):7589-97. PubMed ID: 26687645 [Abstract] [Full Text] [Related]
11. Schedule-dependent antitumor effects of 5-fluorouracil combined with sorafenib in hepatocellular carcinoma. Deng L, Ren Z, Jia Q, Wu W, Shen H, Wang Y. BMC Cancer; 2013 Jul 29; 13():363. PubMed ID: 23895220 [Abstract] [Full Text] [Related]
12. Tyrosine kinase inhibitor PTK/ZK enhances the antitumor effects of interferon-α/5-fluorouracil therapy for hepatocellular carcinoma cells. Murakami M, Kobayashi S, Marubashi S, Tomimaru Y, Noda T, Wada H, Eguchi H, Takeda Y, Tanemura M, Umeshita K, Doki Y, Mori M, Nagano H. Ann Surg Oncol; 2011 Feb 29; 18(2):589-96. PubMed ID: 20811948 [Abstract] [Full Text] [Related]
13. [Influence of combined cyclosporine A and tacrolimus with 5-fluorouracil on hepatocellular carcinoma rats]. Yang FC, Zheng SS, Li MW, Zeng QL, Jiang GP, Xie HY. Zhonghua Wai Ke Za Zhi; 2003 Jun 29; 41(6):449-52. PubMed ID: 12895356 [Abstract] [Full Text] [Related]
14. Allicin sensitizes hepatocellular cancer cells to anti-tumor activity of 5-fluorouracil through ROS-mediated mitochondrial pathway. Zou X, Liang J, Sun J, Hu X, Lei L, Wu D, Liu L. J Pharmacol Sci; 2016 Aug 29; 131(4):233-40. PubMed ID: 27177453 [Abstract] [Full Text] [Related]
15. Effects of tacrolimus on proliferation, apoptosis, and fluorouracil sensitivity of liver cancer cell line of SMMC-7721. Cao XW, Fu ZR, Ding GS. Hepatobiliary Pancreat Dis Int; 2005 May 29; 4(2):269-73. PubMed ID: 15908328 [Abstract] [Full Text] [Related]